Drugplain

Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy 45 mg/mL

OCTISALATE, TITANIUM DIOXIDE · EMULSION · Parfums Christian Dior

No Recall History
Plain English

Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy is a emulsion containing octisalate, titanium dioxide at 45 mg/mL, taken topical. Manufactured by Parfums Christian Dior.

Key Facts

Brand Name
Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy
Generic Name
OCTISALATE, TITANIUM DIOXIDE
NDC Code (Product)
61957-3203
Manufacturer
Parfums Christian Dior
Strength
45 mg/mL
Dosage Form
EMULSION
Route
TOPICAL
Marketing Status
Application #
M020
Marketing Start
03/01/2026

Recall History

No Recall History

Frequently Asked Questions

What is Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy used for?

Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy contains OCTISALATE, TITANIUM DIOXIDE. It is a emulsion taken topical. Consult your doctor for specific uses.

Is Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy a controlled substance?

Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy is not classified as a controlled substance by the DEA.

What is the generic name for Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy?

The generic name for Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy is OCTISALATE, TITANIUM DIOXIDE. There are 12 other brand versions of OCTISALATE, TITANIUM DIOXIDE.

What is the NDC code for Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy 45 mg/mL?

The NDC (National Drug Code) for Dior Forever Skin Glow Flawless Radiant Skin True Foundation SPF 25 0CR Cool Fosy 45 mg/mL is 61957-3203, listed by Parfums Christian Dior.

Product NDC

61957-3203

Package NDC

61957-3203-0

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)